Top Diagnostics Startups in 2027

Radiology is the second most used healthcare service, used by over 51% of the workforce annually. Despite the critical role of radiology in healthcare, the process for undergoing a medical imaging exam has remained unchanged for decades. OneImaging is solving this with a concierge approach and a premium-quality radiology network of over 4,000 vetted providers across 48 states, which also reduces imaging costs by 60-80%. Our solution helps patients and families access essential radiology services at fair prices and without surprise bills, all while delivering immediate savings and ROI for employers and payers on every exam.

Welcome to HeartFlow, recipient of the 2011 EuroPCR Innovation award. Read to learn about non-invasive FFRCT (computed FFR), DISCOVER-FLOW and DeFACTO studies

The risk of dying in the 30 days after surgery is 1,000-fold higher than intraoperative risk. The 30 days after surgery, if considered a disease, would be the third-leading cause of death in the United States. General ward respiratory failure is common, profound, and prolonged. We are looking to dent this substantial cause of morbidity and mortality with our AI engine powered by our medical-grade contactless radar sensor, clinic software, and proprietary algorithms.

Saphetor is a personalized medicine diagnostics company working to improve outcomes for patients by offering clinicians data-driven solutions for making better diagnoses and selecting optimal therapies. To do this, Saphetor is pioneering the automation of the currently laborious and disparate processes required for genome-scale analyses and annotation of data from NGS – Next Generation Sequencing. Saphetor already has created an innovative approach for aggregating and efficiently interrogating more than 8 billion individual annotations from multiple external sources. This work, which leverages proprietary algorithms, affords Saphetor the power needed to rapidly identify pathogenic variants with higher confidence (i.e. fewer false positives and fewer false negatives) than competitors. Saphetor sells access to its technology platform for automated NGS data analysis and annotation and also offers value added content (i.e. reports written by molecular geneticists) to medical geneticists.

Informuta is an infectious disease intelligence company that forecasts drug resistance trajectories to guide antibiotic selection with precision and quantify treatment-emergent resistance risk for the first time. Informuta uses proprietary AI and novel predictive genomic biomarkers to give clinicians the confidence to choose therapies that won’t fail their most vulnerable patients - transforming antibiotic prescribing from reactive to predictive and empowering smarter, future-proofed decisions.